Preferences for Injectable Lipid-Lowering Therapies in Japanese Patients with Atherosclerotic Cardiovascular Disease: Findings from a Japanese Cross-sectional Study.

ABSTRACT:

Introduction

Understanding patient preferences for injectable lipid-lowering therapies (LLTs) is crucial for optimizing adherence and outcomes for preventing atherosclerotic cardiovascular diseases (ASCVDs). This study aimed to quantify patient preferences for injectable LLTs among Japanese patients with ASCVDs.

Methods

This cross-sectional study was conducted from January to February 2024 using an online discrete choice experiment. Participants were recruited from the Rakuten Insight Disease Panel. A total of 59,611 individuals accessed the survey, and eligible adults aged ≥ 18 years with a history of dyslipidemia and currently receiving statin treatment were included. Participants were categorized into primary (n = 110) or secondary (n = 415) prevention groups based on the

SUBMITTER: Toda M 

PROVIDER: S-EPMC12474632 | biostudies-literature | 2025 Oct

REPOSITORIES: biostudies-literature